• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Mettler-Toledo International Inc. Reports Second Quarter 2024 Results

    8/1/24 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $MTD alert in real time by email

    Mettler-Toledo International Inc. (NYSE:MTD) today announced second quarter results for 2024. Provided below are the highlights:

    • Reported sales declined 4% compared with the prior year. In local currency, sales decreased 2% in the quarter as currency reduced sales growth by 2%.
    • Net earnings per diluted share as reported (EPS) were $10.37, compared with $9.69 in the prior-year period. Adjusted EPS was $9.65, a decrease of 5% over the prior-year amount of $10.19. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules.

    Second Quarter Results

    Patrick Kaltenbach, President and Chief Executive Officer, stated, "Our team continued to execute very well in the second quarter and delivered good Laboratory sales growth in Europe and the Americas. As expected, market conditions in China remained weak. We continue to benefit from our productivity and margin initiatives, which helped mitigate the impact of foreign exchange headwinds and supported better-than-expected financial results."

    GAAP Results

    EPS in the quarter was $10.37, compared with the prior-year amount of $9.69. EPS included a one-time non-cash tax benefit of $1.07 per share.

    Compared with the prior year, total reported sales declined 4% to $946.8 million. By region, reported sales increased 5% in Europe and 2% in the Americas and declined 16% in Asia/Rest of World. Earnings before taxes amounted to $243.2 million, compared with $263.4 million in the prior year.

    Non-GAAP Results

    Adjusted EPS was $9.65, a decrease of 5% over the prior-year amount of $10.19.

    Compared with the prior year, total sales in local currency declined 2% as currency reduced sales growth by 2%. By region, local currency sales increased 6% in Europe and 2% in the Americas and declined 12% in Asia/Rest of World. Adjusted Operating Profit amounted to $284.1 million, compared with the prior-year amount of $307.7 million.

    Adjusted EPS and Adjusted Operating Profit are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.

    Six Month Results

    GAAP Results

    EPS was $18.60, compared with the prior-year amount of $18.15, and included the previously mentioned one-time non-cash tax benefit of $1.07 per share.

    Compared with the prior year, total reported sales declined 2% to $1.873 billion. By region, reported sales increased 6% in Europe and 3% in the Americas and declined 14% in Asia/Rest of World. Earnings before taxes amounted to $463.7 million, compared with $490.0 million in the prior year.

    Non-GAAP Results

    Adjusted EPS was $18.53, a decrease of 2% over the prior-year amount of $18.82.

    Compared with the prior year, total sales in local currency declined 1% as currency reduced sales growth by 1%. By region, local currency sales increased 6% in Europe and 2% in the Americas and declined 11% in Asia/Rest of World. Excluding the first quarter benefit from delayed fourth quarter 2023 shipments, year-to-date local currency sales declined 4%, including flat local currency sales in Europe and the Americas and a 12% decline in Asia/Rest of World. Adjusted Operating Profit amounted to $551.4 million, compared with the prior-year amount of $574.2 million.

    Adjusted EPS and Adjusted Operating Profit are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.

    Outlook

    Management cautions that market conditions are uncertain and could change quickly. Based on today's assessment, management anticipates local currency sales for the third quarter of 2024 will increase approximately 1%, and Adjusted EPS is forecast to be $9.90 to $10.05, representing growth of 1% to 3%. Included in the third quarter guidance is an estimated 1% headwind to Adjusted EPS growth due to adverse currency.

    For the full year, management anticipates local currency sales in 2024 will increase approximately 2%, and Adjusted EPS is forecast to be in the range of $40.20 to $40.50, representing growth of approximately 6% to 8%. Included in the full year guidance is an estimated 2% headwind to Adjusted EPS growth due to adverse currency. This compares with previous local currency sales growth guidance of approximately 2% and Adjusted EPS guidance of $39.90 to $40.40.

    The Company does not provide GAAP financial measures on a forward-looking basis because we are unable to predict with reasonable certainty and without unreasonable effort the timing and amount of future restructuring and other non-recurring items.

    Conclusion

    Kaltenbach concluded, "Market conditions globally have remained soft, especially in China. However, we expect our local currency sales to return to growth in the second half of the year primarily due to easier comparisons, as well as execution of our Spinnaker sales and marketing program and leveraging our innovative product portfolio. We remain focused on continuing to strengthen our Company for the future and believe we are in an excellent position to continue to gain market share and deliver future growth."

    Other Matters

    The Company will host a conference call to discuss its quarterly results tomorrow morning (Friday, August 2) at 7:30 a.m. Eastern Time. To listen to a live webcast or replay of the call, visit the investor relations page on the Company's website at investor.mt.com. The presentation referenced on the conference call will be located on the website prior to the call.

    METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.

    Forward-Looking Statements Disclaimer

    You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties, including statements about expected revenue growth, inflation, ongoing developments related to Ukraine, and the Israel-Hamas war. You can identify forward-looking statements by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential," or "continue."

    We make forward-looking statements about future events or our future financial performance, including earnings and sales growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, planned research and development efforts and product introductions, adequacy of facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, customer demand, our competitive position, pricing, capital expenditures, cash flow, tax-related matters, the impact of foreign currencies, compliance with laws, effects of acquisitions, and the impact of inflation, ongoing developments related to Ukraine, and the Israel-Hamas war on our business.

    Our forward-looking statements may not be accurate or complete, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including inflation, ongoing developments related to Ukraine, and the Israel-Hamas war. See in particular "Factors Affecting Our Future Operating Results" and "Management's Discussion and Analysis of Financial Condition and Results of Operations."

     

    METTLER-TOLEDO INTERNATIONAL INC.

    CONSOLIDATED STATEMENTS OF OPERATIONS
    (amounts in thousands except share data)
    (unaudited)
     

    Three months ended

     

     

     

     

    Three months ended

     

     

    June 30, 2024

     

     

    % of sales

     

    June 30, 2023

     

    % of sales

     
    Net sales

    $

    946,750

     

    (a)

    100.0

     

    $

    982,117

     

    100.0

     

    Cost of sales

     

    381,082

     

    40.3

     

     

    398,574

     

    40.6

     

    Gross profit

     

    565,668

     

    59.7

     

     

    583,543

     

    59.4

     

     
    Research and development

     

    45,771

     

    4.8

     

     

    47,245

     

    4.8

     

    Selling, general and administrative

     

    235,796

     

    24.9

     

     

    228,594

     

    23.3

     

    Amortization

     

    18,178

     

    1.9

     

     

    18,042

     

    1.8

     

    Interest expense

     

    18,950

     

    2.0

     

     

    19,249

     

    2.0

     

    Restructuring charges

     

    5,329

     

    0.6

     

     

    8,021

     

    0.8

     

    Other charges (income), net

     

    (1,533

    )

    (0.2

    )

     

    (1,011

    )

    (0.1

    )

    Earnings before taxes

     

    243,177

     

    25.7

     

     

    263,403

     

    26.8

     

     
    Provision for taxes

     

    21,363

     

    2.3

     

     

    49,476

     

    5.0

     

    Net earnings

    $

    221,814

     

    23.4

     

    $

    213,927

     

    21.8

     

     
    Basic earnings per common share:
    Net earnings

    $

    10.42

     

    $

    9.75

     

    Weighted average number of common shares

     

    21,279,006

     

     

    21,944,645

     

     
    Diluted earnings per common share:
    Net earnings

    $

    10.37

     

    $

    9.69

     

    Weighted average number of common

     

    21,392,550

     

     

    22,080,602

     

    and common equivalent shares
     
    Note:

    (a) Local currency sales decreased 2% as compared to the same period in 2023.

     
    RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT
     
    Three months ended Three months ended
    June 30, 2024 % of sales June 30, 2023 % of sales
     
    Earnings before taxes

    $

    243,177

     

    $

    263,403

     

    Amortization

     

    18,178

     

     

    18,042

     

    Interest expense

     

    18,950

     

     

    19,249

     

    Restructuring charges

     

    5,329

     

     

    8,021

     

    Other charges (income), net

     

    (1,533

    )

     

    (1,011

    )

    Adjusted operating profit

    $

    284,101

     

    (b)

    30.0

     

    $

    307,704

     

    31.3

     

     
    Note:

    (b) Adjusted operating profit decreased 8% as compared to the same period in 2023.

     

    METTLER-TOLEDO INTERNATIONAL INC.

    CONSOLIDATED STATEMENTS OF OPERATIONS
    (amounts in thousands except share data)
    (unaudited)
     

    Six months ended

     

     

     

     

    Six months ended

     

     

    June 30, 2024

     

     

    % of sales

     

    June 30, 2023

     

    % of sales

     
    Net sales

    $

    1,872,699

     

    (a)

    100.0

     

    $

    1,910,855

     

    100.0

     

    Cost of sales

     

    758,898

     

    40.5

     

     

    780,746

     

    40.9

     

    Gross profit

     

    1,113,801

     

    59.5

     

     

    1,130,109

     

    59.1

     

     
    Research and development

     

    92,186

     

    4.9

     

     

    92,722

     

    4.9

     

    Selling, general and administrative

     

    470,186

     

    25.1

     

     

    463,232

     

    24.2

     

    Amortization

     

    36,406

     

    1.9

     

     

    35,821

     

    1.9

     

    Interest expense

     

    38,182

     

    2.0

     

     

    37,433

     

    2.0

     

    Restructuring charges

     

    14,993

     

    0.8

     

     

    12,295

     

    0.6

     

    Other charges (income), net

     

    (1,876

    )

    (0.0

    )

     

    (1,407

    )

    (0.1

    )

    Earnings before taxes

     

    463,724

     

    24.8

     

     

    490,013

     

    25.6

     

     
    Provision for taxes

     

    64,401

     

    3.5

     

     

    87,660

     

    4.5

     

    Net earnings

    $

    399,323

     

    21.3

     

    $

    402,353

     

    21.1

     

     
    Basic earnings per common share:
    Net earnings

    $

    18.70

     

    $

    18.28

     

    Weighted average number of common shares

     

    21,358,339

     

     

    22,013,662

     

     
    Diluted earnings per common share:
    Net earnings

    $

    18.60

     

    $

    18.15

     

    Weighted average number of common

     

    21,468,995

     

     

    22,164,394

     

    and common equivalent shares
     
    Note:

    (a) Local currency sales decreased 1% as compared to the same period in 2023.

     
    RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT
     

    Six months ended

     

     

     

     

    Six months ended

     

     

    June 30, 2024

     

     

    % of sales

     

    June 30, 2023

     

    % of sales

     
    Earnings before taxes

    $

    463,724

     

    $

    490,013

     

    Amortization

     

    36,406

     

     

    35,821

     

    Interest expense

     

    38,182

     

     

    37,433

     

    Restructuring charges

     

    14,993

     

     

    12,295

     

    Other charges (income), net

     

    (1,876

    )

     

    (1,407

    )

    Adjusted operating profit

    $

    551,429

     

    (b)

    29.4

     

    $

    574,155

     

    (b)

    30.0

     

     
    Note:

    (b) Adjusted operating profit decreased 4% as compared to the same period in 2023.

    METTLER-TOLEDO INTERNATIONAL INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (amounts in thousands)

    (unaudited)

     
     
    June 30, 2024 December 31, 2023
     
    Cash and cash equivalents

    $

    70,810

     

    $

    69,807

     

    Accounts receivable, net

     

    634,710

     

     

    663,893

     

    Inventories

     

    366,395

     

     

    385,865

     

    Other current assets and prepaid expenses

     

    106,392

     

     

    110,638

     

    Total current assets

     

    1,178,307

     

     

    1,230,203

     

     
    Property, plant and equipment, net

     

    768,664

     

     

    803,374

     

    Goodwill and other intangibles assets, net

     

    933,513

     

     

    955,537

     

    Other non-current assets

     

    368,680

     

     

    366,441

     

    Total assets

    $

    3,249,164

     

    $

    3,355,555

     

     
    Short-term borrowings and maturities of long-term debt

    $

    311,246

     

    $

    192,219

     

    Trade accounts payable

     

    199,462

     

     

    210,411

     

    Accrued and other current liabilities

     

    770,474

     

     

    778,452

     

    Total current liabilities

     

    1,281,182

     

     

    1,181,082

     

     
    Long-term debt

     

    1,746,638

     

     

    1,888,620

     

    Other non-current liabilities

     

    374,106

     

     

    435,791

     

    Total liabilities

     

    3,401,926

     

     

    3,505,493

     

     
    Shareholders' equity

     

    (152,762

    )

     

    (149,938

    )

    Total liabilities and shareholders' equity

    $

    3,249,164

     

    $

    3,355,555

     

    METTLER-TOLEDO INTERNATIONAL INC.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
    (amounts in thousands)
    (unaudited)

     

     

     

     

     

     

     

    Three months ended

     

    Six months ended

    June 30,

     

    June 30,

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     
    Cash flow from operating activities:
    Net earnings

    $

    221,814

     

    $

    213,927

     

    $

    399,323

     

    $

    402,353

     

    Adjustments to reconcile net earnings to
    net cash provided by operating activities:
    Depreciation

     

    12,351

     

     

    12,194

     

     

    24,873

     

     

    24,217

     

    Amortization

     

    18,178

     

     

    18,042

     

     

    36,406

     

     

    35,821

     

    Deferred tax benefit

     

    (1,774

    )

     

    (2,368

    )

     

    (3,837

    )

     

    (1,766

    )

    One-time non-cash discrete tax benefit

     

    (22,982

    )

     

    -

     

     

    (22,982

    )

     

    -

     

    Other

     

    4,541

     

     

    4,195

     

     

    9,263

     

     

    8,222

     

    Increase (decrease) in cash resulting from changes in
    operating assets and liabilities

     

    25,378

     

     

    20,821

     

     

    4,447

     

     

    (48,774

    )

    Net cash provided by operating activities

     

    257,506

     

     

    266,811

     

     

    447,493

     

     

    420,073

     

     
    Cash flows from investing activities:
    Proceeds from sale of property, plant and equipment

     

    668

     

     

    412

     

     

    668

     

     

    412

     

    Purchase of property, plant and equipment

     

    (23,810

    )

     

    (28,751

    )

     

    (41,201

    )

     

    (51,947

    )

    Proceeds from government funding (a)

     

    -

     

     

    1,264

     

     

    -

     

     

    1,264

     

    Acquisitions

     

    (1,473

    )

     

    -

     

     

    (2,473

    )

     

    (613

    )

    Other investing activities

     

    2,783

     

     

    (15,837

    )

     

    12,239

     

     

    (14,414

    )

    Net cash used in investing activities

     

    (21,832

    )

     

    (42,912

    )

     

    (30,767

    )

     

    (65,298

    )

    Cash flows from financing activities:
    Proceeds from borrowings

     

    572,715

     

     

    475,903

     

     

    1,022,578

     

     

    1,080,921

     

    Repayments of borrowings

     

    (598,912

    )

     

    (455,215

    )

     

    (1,017,192

    )

     

    (958,731

    )

    Proceeds from exercise of stock options

     

    6,305

     

     

    7,614

     

     

    8,136

     

     

    19,087

     

    Repurchases of common stock

     

    (212,499

    )

     

    (250,000

    )

     

    (424,998

    )

     

    (499,999

    )

    Acquisition contingent consideration payment

     

    -

     

     

    (5,626

    )

     

    -

     

     

    (5,626

    )

    Other financing activities

     

    (1,910

    )

     

    (103

    )

     

    (1,910

    )

     

    (714

    )

    Net cash used in financing activities

     

    (234,301

    )

     

    (227,427

    )

     

    (413,386

    )

     

    (365,062

    )

     
    Effect of exchange rate changes on cash and cash equivalents

     

    (754

    )

     

    (1,983

    )

     

    (2,337

    )

     

    (2,105

    )

     
    Net increase (decrease) in cash and cash equivalents

     

    619

     

     

    (5,511

    )

     

    1,003

     

     

    (12,392

    )

     
    Cash and cash equivalents:
    Beginning of period

     

    70,191

     

     

    89,085

     

     

    69,807

     

     

    95,966

     

    End of period

    $

    70,810

     

    $

    83,574

     

    $

    70,810

     

    $

    83,574

     

     
    RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW
     
    Net cash provided by operating activities

    $

    257,506

     

    $

    266,811

     

    $

    447,493

     

    $

    420,073

     

    Payments in respect of restructuring activities

     

    5,966

     

     

    5,415

     

     

    15,680

     

     

    7,398

     

    Transition tax payment

     

    10,723

     

     

    8,042

     

     

    10,723

     

     

    8,042

     

    Proceeds from sale of property, plant and equipment

     

    668

     

     

    412

     

     

    668

     

     

    412

     

    Purchase of property, plant and equipment, net (a)

     

    (23,810

    )

     

    (24,907

    )

     

    (41,201

    )

     

    (44,815

    )

    Acquisition payments (b)

     

    -

     

     

    4,775

     

     

    -

     

     

    4,775

     

    Adjusted free cash flow

    $

    251,053

     

    $

    260,548

     

    $

    433,363

     

    $

    395,885

     

    Notes:

    (a)

    In September 2021, the Company entered into an agreement with the U.S. Department of Defense to increase the domestic production capacity of pipette tips and enhance manufacturing automation and logistics. The Company received funding of $35.8 million in prior years, which offset capital expenditures. During the three and six months ended June 30, 2023 the Company received funding proceeds of $1.3 million. During the three and six months ended June 30, 2023 the related purchase of property, plant and equipment of $3.8 million and $7.1 million, respectively, are excluded from Adjusted free cash flow.

    (b)

    Includes $4.4 million of the PendoTECH contingent consideration payment that was reported in net cash provided by operating activities as required by U.S. GAAP for the three and six months ended June 30, 2023.

     

    METTLER-TOLEDO INTERNATIONAL INC.

    OTHER OPERATING STATISTICS
     
    SALES GROWTH BY DESTINATION
    (unaudited)
     

    Americas

     

    Europe

     

    Asia/RoW

     

    Total

     
    U.S. Dollar Sales Growth
    Three Months Ended June 30, 2024

    2%

     

    5%

     

    (16%)

     

    (4%)

    Six Months Ended June 30, 2024

    3%

     

    6%

     

    (14%)

     

    (2%)

     

     

     

     

     

     

     

    Local Currency Sales Growth

     

     

     

     

     

     

     

    Three Months Ended June 30, 2024

    2%

     

    6%

     

    (13%)

     

    (2%)

    Six Months Ended June 30, 2024

    2%

     

    6%

     

    (11%)

     

    (1%)

    Note:

    (a)

    The Company estimates net sales for the six months ended June 30, 2024 benefited by 3% from recovering previously delayed shipments from the fourth quarter of 2023. By geographic destination, net sales benefited approximately 2% in the Americas, 6% in Europe and 1% in Asia/Rest of World.

     

    RECONCILIATION OF DILUTED EPS AS REPORTED TO ADJUSTED DILUTED EPS

    (unaudited)
     

    Three months ended

     

    Six months ended

    June 30,

     

    June 30,

     

    2024

     

     

     

     

    2023

     

     

     

    % Growth

     

     

    2024

     

     

     

     

    2023

     

     

     

    % Growth

     
    EPS as reported, diluted

    $

    10.37

     

    $

    9.69

     

    7

    %

    $

    18.60

     

    $

    18.15

     

    2

    %

     
    Purchased intangible amortization, net of tax

     

    0.24

     

    (a)

     

    0.23

     

    (a)

     

    0.47

     

    (a)

     

    0.46

     

    (a)
    Restructuring charges, net of tax

     

    0.20

     

    (b)

     

    0.29

     

    (b)

     

    0.56

     

    (b)

     

    0.45

     

    (b)
    Income tax expense

     

    (1.16

    )

    (c)

     

    (0.02

    )

    (c)

     

    (1.10

    )

    (c)

     

    (0.24

    )

    (c)
     
    Adjusted EPS, diluted

    $

    9.65

     

    $

    10.19

     

    -5

    %

    $

    18.53

     

    $

    18.82

     

    -2

    %

    Notes:

    (a)

    Represents the EPS impact of purchased intangibles amortization of $6.5 million ($5.0 million net of tax) and $6.7 million ($5.2 million net of tax) for the three months ended June 30, 2024 and 2023, and of $13.1 million ($10.1 million net of tax) and $13.3 million ($10.3 million net of tax) for the six months ended June 30, 2024 and 2023, respectively.

    (b)

    Represents the EPS impact of restructuring charges of $5.3 million ($4.3 million after tax) and $8.0 million ($6.5 million after tax) for the three months ended June 30, 2024 and 2023, and $15.0 million ($12.1 million after tax) and $12.3 million ($10.0 million after tax) for the six months ended June 30, 2024 and 2023, respectively, which primarily include employee related costs.

    (c)

    Represents the EPS impact of the difference between our quarterly and estimated annual tax rate before non-recurring discrete items during the three and six months ended June 30, 2024 and 2023 due to the timing of excess tax benefits associated with stock option exercises. Also includes a reported EPS reduction of $1.07 for the three and six months ended June 30, 2024 for the one-time non-cash discrete tax benefit resulting from the reduction of uncertain tax position liabilities related to the settlement of a tax audit.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240801458990/en/

    Get the next $MTD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MTD

    DatePrice TargetRatingAnalyst
    5/20/2025$1350.00Neutral → Buy
    UBS
    5/5/2025$1110.00Underperform → Hold
    Jefferies
    5/5/2025$1100.00Underperform → Hold
    Jefferies
    4/7/2025$1400.00Neutral → Buy
    Citigroup
    1/2/2025$1375.00 → $1450.00In-line → Outperform
    Evercore ISI
    12/13/2024Peer Perform
    Wolfe Research
    12/11/2024$1200.00 → $1300.00Sell → Neutral
    Citigroup
    8/28/2024$1400.00Equal Weight
    Wells Fargo
    More analyst ratings

    $MTD
    SEC Filings

    See more
    • SEC Form SD filed by Mettler-Toledo International Inc.

      SD - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/30/25 8:39:40 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. filed SEC Form 8-K: Leadership Update

      8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/12/25 4:47:54 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

      5/6/25 11:25:47 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Diggelmann Roland D bought $323,360 worth of shares (315 units at $1,026.54), increasing direct ownership by 350% to 405 units (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      11/15/23 9:00:20 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Kelly Michael A sold $1,231,846 worth of shares (1,062 units at $1,159.93) and exercised 1,062 shares at a strike of $312.36 (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      5/30/25 8:45:39 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Head of Process Analytics Keller Gerry was granted 88 shares, increasing direct ownership by 1,467% to 94 units (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      5/12/25 5:14:29 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Head of Eur & NA Market Orgs De La Guerroniere Marc was granted 186 shares (SEC Form 4)

      4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

      5/12/25 5:13:12 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Financials

    Live finance-specific insights

    See more
    • Mettler-Toledo International Inc. Reports First Quarter 2025 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year. Net earnings per diluted share as reported (EPS) were $7.81, compared with $8.24 in the prior-year period. Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chie

      5/1/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. to Host First Quarter 2025 Earnings Conference Call

      Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its first quarter 2025 financial results after the market close on Thursday, May 1, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our s

      4/3/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Reports Fourth Quarter 2024 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced fourth quarter results for 2024. Provided below are the highlights: Reported and local currency sales increased 12% compared with the prior year. Net earnings per diluted share as reported (EPS) were $11.96, compared with $8.52 in the prior-year period. Adjusted EPS was $12.41, an increase of 32% over the prior-year amount of $9.40. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Fourth Quarter Results Patrick Kaltenbach, President and Chief Executive Officer, stated, "We had a strong finish to the year as we capitalized on very good customer deman

      2/6/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/13/24 5:09:38 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/10/23 1:38:29 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

      SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

      2/10/22 5:03:51 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $MTD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $MTD
    Leadership Updates

    Live Leadership Updates

    See more

    $MTD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Mettler-Toledo upgraded by UBS with a new price target

      UBS upgraded Mettler-Toledo from Neutral to Buy and set a new price target of $1,350.00

      5/20/25 8:01:57 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo upgraded by Jefferies with a new price target

      Jefferies upgraded Mettler-Toledo from Underperform to Hold and set a new price target of $1,110.00

      5/5/25 8:42:51 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo upgraded by Jefferies with a new price target

      Jefferies upgraded Mettler-Toledo from Underperform to Hold and set a new price target of $1,100.00

      5/5/25 8:26:45 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Announces Change to Board of Directors

      Columbus, OH, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Mettler-Toledo International Inc. (NYSE:MTD) announced today that Olivier Filliol informed the Company that he will not stand for re-election to the Board of Directors in May 2023. Mr. Filliol joined the Board in 2009 and served as President and CEO from January 1, 2008 through March 31, 2021.  Robert F. Spoerry, Chair of the Board, stated, "We want to sincerely thank Olivier for his many highly valuable contributions, and we are grateful for the unique expertise that he has brought to the Company. Olivier was instrumental in ensuring a successful CEO transition to Patrick Kaltenbach, which positions the Company well to continue its successf

      11/23/22 8:00:00 AM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Reports First Quarter 2025 Results

      Mettler-Toledo International Inc. (NYSE:MTD) today announced first quarter results for 2025. Provided below are the highlights: Reported sales declined 5% compared with the prior year. In local currency, sales decreased 3% compared with the prior year and grew 3% excluding the recovery of delayed shipments in the prior year. Net earnings per diluted share as reported (EPS) were $7.81, compared with $8.24 in the prior-year period. Adjusted EPS was $8.19, a decrease of 8% over the prior-year amount of $8.89. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results Patrick Kaltenbach, President and Chie

      5/1/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. Announces Webcast of Presentation at the BofA Securities 2025 Healthcare Conference

      Mettler-Toledo International Inc. (NYSE:MTD) today announced it will present at the BofA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025, at 4:20pm Pacific Time (7:20pm Eastern Time). A live webcast of the presentation will be available on the Company's investor relations website at investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide

      4/25/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Mettler-Toledo International Inc. to Host First Quarter 2025 Earnings Conference Call

      Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its first quarter 2025 financial results after the market close on Thursday, May 1, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our s

      4/3/25 4:30:00 PM ET
      $MTD
      Biotechnology: Laboratory Analytical Instruments
      Industrials